Cliff Asness's DNA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 170,555 shares of Ginkgo Bioworks Holdings, Inc. (DNA) worth $1.42 M, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in DNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 259,078 shares. Largest reduction occurred in Q3 2024, reducing 218,647 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Ginkgo Bioworks Holdings (DNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ginkgo Bioworks Holdings (DNA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +19,860 | Add 13.18% | 170,555 | $8.31 |
| Q3 2025 | -13,095 | Reduce 7.99% | 150,695 | $14.58 |
| Q2 2025 | +4,851 | Add 3.05% | 163,790 | $11.25 |
| Q1 2025 | +121,326 | Add 322.56% | 158,939 | $5.70 |
| Q4 2024 | -2,818 | Reduce 6.97% | 37,613 | $9.82 |
| Q3 2024 | -218,647 | Reduce 84.39% | 40,431 | $8.15 |
| Q2 2024 | +259,078 | New Buy | 259,078 | $13.09 |
| Q1 2024 | -980 | Sold Out | 0 | $0.00 |
| Q4 2023 | +393 | Add 66.95% | 980 | $67.63 |
| Q3 2023 | +587 | New Buy | 587 | $72.24 |
| Q4 2022 | -15,310 | Sold Out | 0 | $0.00 |
| Q3 2022 | +15,310 | New Buy | 15,310 | $124.82 |
Cliff Asness's Ginkgo Bioworks Holdings Investment FAQs
Cliff Asness first purchased Ginkgo Bioworks Holdings, Inc. (DNA) in Q3 2022, acquiring 15,310 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Ginkgo Bioworks Holdings, Inc. (DNA) for 12 quarters since Q3 2022.
Cliff Asness's largest addition to Ginkgo Bioworks Holdings, Inc. (DNA) was in Q2 2024, adding 259,078 shares worth $3.39 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 170,555 shares of Ginkgo Bioworks Holdings, Inc. (DNA), valued at approximately $1.42 M.
As of the Q4 2025 filing, Ginkgo Bioworks Holdings, Inc. (DNA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Ginkgo Bioworks Holdings, Inc. (DNA) was 259,078 shares, as reported at the end of Q2 2024.